Literature DB >> 8704211

Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias.

T Pabst1, J Schwaller, M J Bellomo, M Oestreicher, D Mühlematter, A Tichelli, A Tobler, M F Fey.   

Abstract

Microsatellites are important highly polymorphic genetic markers dispersed in the human genome. Using a panel of 22 (CA)n repeat microsatellite markers mapped to recurrent breakpoint cluster regions specifically involved in leukemia, we investigated 114 adult leukemias (25 acute lymphocytic leukemia [ALL], 32 acute myeloid leukemia [AML], 36 chronic lymphocytic leukemia [CLL], and 21 chronic myeloid leukemia [CML] in chronic phase) for somatic mutations at these loci. In each patient, DNA from fresh leukemia samples was analyzed alongside normal constitutive DNA from buccal epithelium. We detected loss of heterozygosity (LOH) in 81 of 114 patients (ALL 16/25, AML 25/32, CLL 30/36, CML 10/21). Deletions were most often seen in ALL at 11q23 and 19p13; in AML at 8q22 and 11q23; in CLL at 13q14.3, 11q13, and 11q23; and in CML at 3q26. Only six deletions were reported in 74 karyotypes analyzed, whereas in these same cases, 91 LOH events were detected by microsatellites. Of 26 leukemias with a normal karyotype, 16 nevertheless showed at least one LOH by microsatellite analysis. Replication errors were found in 10 of 114 patients (8.8%). Thus, microsatellite instability is rare in leukemia in contrast to many solid tumors. Our findings suggest that in adult leukemia, LOH may be an important genetic event in addition to typical chromosomal translocations. LOH may point to the existence of tumor suppressor genes involved in leukemogenesis to a degree that has hitherto been underestimated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704211

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Authors:  M Sol Mateo; M Mollejo; R Villuendas; P Algara; M Sánchez-Beato; B Martinez-Delgado; P Martínez; M A Piris
Journal:  Mol Pathol       Date:  1998-10

Review 2.  Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state.

Authors:  Tomasz Skorski
Journal:  Leuk Lymphoma       Date:  2011-02

3.  Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.

Authors:  H Liang; J Fairman; D F Claxton; P C Nowell; E D Green; L Nagarajan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Assessment of three generations of mice derived by ICSI using freeze-dried sperm.

Authors:  Ming-Wen Li; Brandon J Willis; Stephen M Griffey; Jimmy L Spearow; K C Kent Lloyd
Journal:  Zygote       Date:  2009-05-06       Impact factor: 1.442

5.  Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia.

Authors:  E Niv; Y Bomstein; M Yuklea; M Lishner
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

6.  Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL.

Authors:  Natalya Risinskaya; Yana Kozhevnikova; Olga Gavrilina; Julia Chabaeva; Ekaterina Kotova; Anna Yushkova; Galina Isinova; Ksenija Zarubina; Tatiana Obukhova; Sergey Kulikov; Hunan Julhakyan; Andrey Sudarikov; Elena Parovichnikova
Journal:  Genes (Basel)       Date:  2022-02-23       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.